Read the latest press releases for 4D pharma plc.

Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.

Presentations
4D pharma Announces Instructions for Converting AIM Listed Ordinary Shares into Nasdaq Listed ADSs
7 Apr 2021, 07:00
This announcement is intended to guide holders of Ordinary Shares, which are admitted to trading on…
Presentations
Final Results for the year ended 31 December 2020
1 Apr 2021, 07:00
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live…
Presentations
Completion of Merger with Longevity Acquisition Corporation and admission of American Depositary Shares to trading on NASDAQ
22 Mar 2021, 07:00
4D pharma's business combination with Longevity Acquisition Corporation has now become effective,…
4D pharma and Longevity receive shareholder approval to complete business combination
18 Mar 2021, 13:30
4D pharma and Longevity Acquisition Corporation receive shareholder approval to complete business…
4D Pharma Announces Private Placement
17 Mar 2021, 13:00
Company expects to complete merger with Longevity Acquisition Corporation and its American…
4D pharma to Present at Upcoming Investor Conferences in March
3 Mar 2021, 07:00
4D pharma management will present and meet with investors at three upcoming investor conferences…
4D pharma Appoints Paul Maier to the Board as Non-Executive Director
1 Mar 2021, 07:00
4D pharma announces the appointment of Paul Maier as Non-Executive Director of the Board. Mr Maier…
4D pharma Appoints John Beck as Chief Financial Officer
1 Mar 2021, 07:00
4D pharma announces the appointment of John Beck as Chief Financial Officer (CFO) and member of the…
4D pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ
26 Feb 2021, 07:00
4D pharma to list ADSs on NASDAQ in conjunction with the merger agreement between 4D pharma and…
4D pharma to Participate in Cantor Fitzgerald Microbiome Leaders Panel
16 Feb 2021, 07:00
Duncan Peyton, Chief Executive Officer of 4D pharma, will participate in Cantor Fitzgerald's virtual…
4D pharma presents update on oncology program
3 Feb 2021, 07:00
4D pharma announces progress on activities in its development program for lead immuno-oncology…
4D pharma to Participate in 5th Microbiome Movement Drug Development Summit Europe
21 Jan 2021, 08:00
4D today announces its participation in the Microbiome Movement Drug Development Summit - Europe,…
4D pharma Joins Landmark Parkinson’s Progression Markers Initiative
18 Dec 2020, 08:25
A landmark study sponsored by The Michael J. Fox Foundation to better understand Parkinson’s disease…
4D pharma plc Files SEC Forms in Process to Gain NASDAQ Listing Following Merger with Longevity, a Special Purpose Acquisition Company (SPAC)
26 Nov 2020, 07:00
Merger completion and NASDAQ listing expected in Q1 2021. US listing will support and accelerate…

BACK TO TOP